class = “sc-cffd1e67-0 iQNQmc”>
In Switzerland, too, more and more people are resorting to liposuction injections. And this is despite the fact that basic insurance does not cover weight loss drugs. Swiss people often have to pay for the injection themselves, depending on the decision of the health insurance company.
However, so far Novo Nordisk has only made the Wegovy syringe available in some capacity. “Not everyone who wants to buy the product will be able to get it,” Anne Mette Wiis Vogelsang (52), Swiss president of the pharmaceutical company, tells CH-Media. Only patients with the highest medical needs receive it. But he also emphasizes: “Those who really need Wegovy will get it. That’s the most important thing for us.” The feedback they’ve received from doctors and pharmacies has been encouraging.
But now Novo Nordisk is increasing production of Wegovy. “In Switzerland, 11 percent of the population suffers from obesity and 31 percent are overweight. “The need is correspondingly great,” Wiis Vogelsang continued. The company recommends that doctors prescribe the injection only if someone is obese (BMI 30 or more) or very overweight (BMI 27 or more).
BAG is in no rush
The health insurance company probably won’t cover fat grafting anytime soon. Novo Nordisk continues discussions with the Federal Office for Public Health (BAG) regarding the inclusion of Wegovy in the specialty list. “I believe that we will reach a solution soon. It is very important for us that basic insurance covers this type of treatment against obesity,” said the Swiss boss.
Unless BAG sets a price, health insurance companies can decide which treatments will be covered with Wegovy and which will not. However, according to Wiis Vogelsang, this creates “unequal treatment”.
Switzerland’s president prefers the solution to be on the table tomorrow. According to Swiss officials, the price must be determined within 60 days. “Unfortunately it usually takes much longer. “This process needs to be accelerated,” he criticizes in the interview. (kae)
Source :Blick
I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.
